6α-Methyl-17α-bromoprogesterone
Appearance
From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Clinical data | |
---|---|
Other names | 6α-Methyl-17α-bromopregn-4-en-3,20-dione |
Identifiers | |
CAS Number |
|
PubChem CID | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H31BrO2 |
Molar mass | 407.392 g·mol−1 |
3D model (JSmol) | |
| |
|
6α-Methyl-17α-bromoprogesterone is a steroidal progestin related to haloprogesterone (6α-fluoro-17α-bromoprogesterone) that was described in 1963 and was never marketed.[1]
See also
[edit ]References
[edit ]- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 179–. ISBN 978-1-4757-2085-3.
Stub icon
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.